OCULAR THERAPEUTIX, INC Effective Tax Rate
OCULAR THERAPEUTIX, INC (OCUL) reported Effective Tax Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-02-05
- OCULAR THERAPEUTIX, INC effective income tax rate reconciliation, percent for fiscal 2025 was 0.00%.
- OCULAR THERAPEUTIX, INC effective income tax rate reconciliation, percent for fiscal 2015 was 0.00%.
- OCULAR THERAPEUTIX, INC effective income tax rate reconciliation, percent for fiscal 2014 was 0.00%.
- OCULAR THERAPEUTIX, INC effective income tax rate reconciliation, percent for fiscal 2013 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-02-05 |
| 2015-12-31 | 0.00% 10-K · filed 2016-03-10 |
| 2014-12-31 | 0.00% 10-K · filed 2016-03-10 |
| 2013-12-31 | 0.00% 10-K · filed 2016-03-10 |
| 2012-12-31 | 0.00% 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |